Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

693 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19.
Mazzoni A, Di Lauria N, Maggi L, Salvati L, Vanni A, Capone M, Lamacchia G, Mantengoli E, Spinicci M, Zammarchi L, Kiros ST, Rocca A, Lagi F, Colao MG, Parronchi P, Scaletti C, Turco L, Liotta F, Rossolini GM, Cosmi L, Bartoloni A, Annunziato F; COVID-19 Research Group. Mazzoni A, et al. J Clin Invest. 2021 Jun 15;131(12):e149150. doi: 10.1172/JCI149150. J Clin Invest. 2021. PMID: 33939647 Free PMC article.
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent.
Mazzoni A, Salvati L, Maggi L, Capone M, Vanni A, Spinicci M, Mencarini J, Caporale R, Peruzzi B, Antonelli A, Trotta M, Zammarchi L, Ciani L, Gori L, Lazzeri C, Matucci A, Vultaggio A, Rossi O, Almerigogna F, Parronchi P, Fontanari P, Lavorini F, Peris A, Rossolini GM, Bartoloni A, Romagnani S, Liotta F, Annunziato F, Cosmi L. Mazzoni A, et al. J Clin Invest. 2020 Sep 1;130(9):4694-4703. doi: 10.1172/JCI138554. J Clin Invest. 2020. PMID: 32463803 Free PMC article.
Cell-mediated and humoral adaptive immune responses to SARS-CoV-2 are lower in asymptomatic than symptomatic COVID-19 patients.
Mazzoni A, Maggi L, Capone M, Spinicci M, Salvati L, Colao MG, Vanni A, Kiros ST, Mencarini J, Zammarchi L, Mantengoli E, Menicacci L, Caldini E, Romagnani S, Liotta F, Morettini A, Rossolini GM, Bartoloni A, Cosmi L, Annunziato F. Mazzoni A, et al. Eur J Immunol. 2020 Dec;50(12):2013-2024. doi: 10.1002/eji.202048915. Epub 2020 Nov 9. Eur J Immunol. 2020. PMID: 33080068 Free article. Clinical Trial.
Heterogeneous magnitude of immunological memory to SARS-CoV-2 in recovered individuals.
Mazzoni A, Maggi L, Capone M, Vanni A, Spinicci M, Salvati L, Tekle Kiros S, Semeraro R, Pengue L, Colao MG, Magi A, Rossolini GM, Liotta F, Cosmi L, Bartoloni A, Annunziato F. Mazzoni A, et al. Clin Transl Immunology. 2021 May 6;10(5):e1281. doi: 10.1002/cti2.1281. eCollection 2021. Clin Transl Immunology. 2021. PMID: 33976879 Free PMC article.
Impaired response to first SARS-CoV-2 dose vaccination in myeloproliferative neoplasm patients receiving ruxolitinib.
Guglielmelli P, Mazzoni A, Maggi L, Kiros ST, Zammarchi L, Pilerci S, Rocca A, Spinicci M, Borella M, Bartoloni A, Rossolini GM, Annunziato F, Vannucchi AM. Guglielmelli P, et al. Among authors: mazzoni a. Am J Hematol. 2021 Nov 1;96(11):E408-E410. doi: 10.1002/ajh.26305. Epub 2021 Aug 12. Am J Hematol. 2021. PMID: 34331712 Free PMC article. No abstract available.
AIDS patient with severe T cell depletion achieved control but not clearance of SARS-CoV-2 infection.
Spinicci M, Mazzoni A, Borchi B, Graziani L, Mazzetti M, Bartalesi F, Botta A, Tilli M, Pieralli F, Coppi M, Giovacchini N, Colao MG, Saccardi R, Rossolini GM, Annunziato F, Bartoloni A. Spinicci M, et al. Among authors: mazzoni a. Eur J Immunol. 2022 Feb;52(2):352-355. doi: 10.1002/eji.202149574. Epub 2021 Dec 4. Eur J Immunol. 2022. PMID: 34822185 Free PMC article.
SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategies.
Mazzoni A, Vanni A, Spinicci M, Lamacchia G, Kiros ST, Rocca A, Capone M, Di Lauria N, Salvati L, Carnasciali A, Mantengoli E, Farahvachi P, Zammarchi L, Lagi F, Colao MG, Liotta F, Cosmi L, Maggi L, Bartoloni A, Rossolini GM, Annunziato F. Mazzoni A, et al. J Clin Invest. 2022 Mar 15;132(6):e157990. doi: 10.1172/JCI157990. J Clin Invest. 2022. PMID: 35139036 Free PMC article.
SARS-CoV-2 Spike-Specific CD4+ T Cell Response Is Conserved Against Variants of Concern, Including Omicron.
Mazzoni A, Vanni A, Spinicci M, Capone M, Lamacchia G, Salvati L, Coppi M, Antonelli A, Carnasciali A, Farahvachi P, Giovacchini N, Aiezza N, Malentacchi F, Zammarchi L, Liotta F, Rossolini GM, Bartoloni A, Cosmi L, Maggi L, Annunziato F. Mazzoni A, et al. Front Immunol. 2022 Jan 26;13:801431. doi: 10.3389/fimmu.2022.801431. eCollection 2022. Front Immunol. 2022. PMID: 35154116 Free PMC article.
693 results